Myriad Genetics, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership585,277 shares
Latest Disclosed Value $ 2,633,749
Fmr Llc reports 19.21% increase in ownership of MYGN / Myriad Genetics, Inc.

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 585,277 shares of Myriad Genetics, Inc. (US:MYGN) valued at $2,633,746 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 490,945 shares of Myriad Genetics, Inc.. This represents a change in shares of 19.21% during the quarter. The current value of the position is $2,674,716 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MYRIAD GENETICS COM 62855J104 585,277 94,332 19.21 2,634 -12.79 0.0000
2026-02-17 2025-12-31 13F MYRIAD GENETICS COM 62855J104 490,945 92,720 23.28 3,019 4.86 0.0002
2025-11-13 2025-09-30 13F MYRIAD GENETICS COM 62855J104 398,225 49,512 14.20 2,879 55.54 0.0001
2025-08-14 2025-06-30 13F MYRIAD GENETICS COM 62855J104 348,713 176,062 101.98 1,852 20.90 0.0001
2025-05-12 2025-03-31 13F MYRIAD GENETICS COM 62855J104 172,651 67,758 64.60 1,531 6.47 0.0001
2025-02-13 2024-12-31 13F MYRIAD GENETICS COM 62855J104 104,893 35,071 50.23 1,438 -24.79 0.0001
2024-11-13 2024-09-30 13F MYRIAD GENETICS COM 62855J104 69,822 13,319 23.57 1,912 38.35 0.0001
2024-08-13 2024-06-30 13F MYRIAD GENETICS COM 62855J104 56,503 40,703 257.61 1,382 311.31 0.0001
2024-05-13 2024-03-31 13F MYRIAD GENETICS COM 62855J104 15,800 557 3.65 337 15.46 0.0000
2024-02-13 2023-12-31 13F MYRIAD GENETICS COM 62855J104 15,243 -191 -1.24 292 17.81 0.0000
2023-11-13 2023-09-30 13F MYRIAD GENETICS COM 62855J104 15,434 65 0.42 248 -30.62 0.0000
2023-08-11 2023-06-30 13F MYRIAD GENETICS COM 62855J104 15,369 -321 -2.05 356 -2.20 0.0000
2023-08-11 2023-03-31 13F/A-1 MYRIAD GENETICS COM 62855J104 15,690 9,253 143.75 364 291.40 0.0000
2023-05-11 2023-03-31 13F MYRIAD GENETICS COM 62855J104 15,690 9,253 364 0.0000
2023-02-13 2022-12-31 13F MYRIAD GENETICS COM 62855J104 6,437 -10,472 -61.93 93 -71.12 0.0000
2022-11-10 2022-09-30 13F MYRIAD GENETICS COM 62855J104 16,909 264 1.59 322 6.27 0.0000
2022-08-12 2022-06-30 13F MYRIAD GENETICS COM 62855J104 16,645 -123 -0.73 303 -28.37 0.0000
2022-05-13 2022-03-31 13F MYRIAD GENETICS COM 62855J104 16,768 16,246 3,112.26 423 2,921.43 0.0000
2022-02-14 2021-12-31 13F MYRIAD GENETICS COM 62855J104 522 0 0.00 14 -12.50 0.0000
2022-02-14 2021-09-30 13F/A-1 MYRIAD GENETICS COM 62855J104 522 456 690.91 16 700.00 0.0000
2021-11-15 2021-09-30 13F MYRIAD GENETICS COM 62855J104 522 456 16 0.0000
2021-08-13 2021-06-30 13F MYRIAD GENETICS COM 62855J104 66 64 3,200.00 2 0.0000
2021-05-14 2021-03-31 13F MYRIAD GENETICS COM 62855J104 2 -435 -99.54 0 -100.00
2021-02-08 2020-12-31 13F MYRIAD GENETICS COM 62855J104 437 13 3.07 8 33.33 0.0000
2020-11-13 2020-09-30 13F MYRIAD GENETICS COM 62855J104 424 -408 -49.04 6 -40.00 0.0000
2020-08-24 2020-06-30 13F/A-1 MYRIAD GENETICS COM 62855J104 832 -193,860 -99.57 10 -99.64 0.0000
2020-08-13 2020-06-30 13F MYRIAD GENETICS COM 62855J104 832 -193,860 10 0.2457
2020-05-14 2020-03-31 13F MYRIAD GENETICS COM 62855J104 194,692 30,338 18.46 2,786 -37.76 0.0004
2020-02-07 2019-12-31 13F MYRIAD GENETICS COM 62855J104 164,354 163,651 23,278.95 4,476 22,280.00 0.0005
2019-11-13 2019-09-30 13F MYRIAD GENETICS COM 62855J104 703 -169,625 -99.59 20 -99.58 0.0000
2019-08-13 2019-06-30 13F MYRIAD GENETICS COM 62855J104 170,328 -1,161 -0.68 4,732 -16.88 0.0006
2019-05-13 2019-03-31 13F MYRIAD GENETICS COM 62855J104 171,489 0 0.00 5,693 14.20 0.0007
2019-02-13 2018-12-31 13F MYRIAD GENETICS COM 62855J104 171,489 -43,952 -20.40 4,985 -49.70 0.0007
2018-11-09 2018-09-30 13F MYRIAD GENETICS COM 62855J104 215,441 173,141 409.32 9,910 526.82 0.0011
2018-08-10 2018-06-30 13F MYRIAD GENETICS COM 62855J104 42,300 -167 -0.39 1,581 25.98 0.0002
2018-05-14 2018-03-31 13F MYRIAD GENETICS COM 62855J104 42,467 167 0.39 1,255 -13.63 0.0001
2018-02-12 2017-12-31 13F MYRIAD GENETICS COM 62855J104 42,300 42,300 -0.39 1,453 15.78 0.0002
2017-11-13 2017-09-30 13F MYRIAD GENETICS COM 62855J104 0 -112,007 -100.00 0 -100.00
2017-08-29 2017-06-30 13F/A-1 MYRIAD GENETICS COM 62855J104 112,007 -291,893 -72.27 2,894 -62.68 0.0004
2017-08-11 2017-06-30 13F MYRIAD GENETICS COM 62855J104 112,007 -291,893 2,894
2017-05-11 2017-03-31 13F MYRIAD GENETICS COM 62855J104 403,900 5,900 1.48 7,755 16.90 0.0010
2017-02-10 2016-12-31 13F MYRIAD GENETICS COM 62855J104 398,000 315,882 384.67 6,634 292.54 0.0009
2016-11-14 2016-09-30 13F MYRIAD GENETICS COM 62855J104 82,118 -815,882 -90.86 1,690 -93.85 0.0002
2016-08-11 2016-06-30 13F MYRIAD GENETICS COM 62855J104 898,000 -195,400 -17.87 27,479 -32.86 0.0038
2016-05-16 2016-03-31 13F MYRIAD GENETICS COM 62855J104 1,093,400 -1,778,397 -61.93 40,926 -66.98 0.0057
2016-02-12 2015-12-31 13F MYRIAD GENETICS COM 62855J104 2,871,797 608,504 26.89 123,947 46.12 0.0167
2015-11-10 2015-09-30 13F MYRIAD GENETICS COM 62855J104 2,263,293 878,893 63.49 84,828 80.27 0.0121
2015-08-25 2015-06-30 13F/A-1 MYRIAD GENETICS COM 62855J104 1,384,400 -6,289 -0.45 47,056 -4.42 0.0060
2015-08-13 2015-06-30 13F MYRIAD GENETICS COM 62855J104 1,384,400 47,056
2015-05-14 2015-03-31 13F MYRIAD GENETICS COM 62855J104 1,390,689 -443 -0.03 49,231 3.90 0.0063
2015-02-17 2014-12-31 13F MYRIAD GENETICS COM 62855J104 1,391,132 -276,700 -16.59 47,382 -26.34 0.0062
2014-11-14 2014-09-30 13F MYRIAD GENETICS COM 62855J104 1,667,832 0 0.00 64,329 -0.90 0.0087
2014-08-14 2014-06-30 13F MYRIAD GENETICS COM 62855J104 1,667,832 -1,196,696 -41.78 64,912 -33.72 0.0087
2014-05-15 2014-03-31 13F MYRIAD GENETICS COM 62855J104 2,864,528 1,278,365 80.59 97,939 194.31 0.0136
2014-02-13 2013-12-31 13F MYRIAD GENETICS COM 62855J104 1,586,163 10,063 0.64 33,278 -10.15 0.0047
2013-11-14 2013-09-30 13F MYRIAD GENETICS COM 62855J104 1,576,100 552,802 54.02 37,038 34.70 0.0057
2013-09-24 2013-06-30 13F/A-1 MYRIAD GENETICS COM 62855J104 1,023,298 1,023,298 27,496 0.0045
2013-08-14 2013-06-30 13F MYRIAD GENETICS COM 62855J104 1,023,298 27,496 0.0045
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.